AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 81 filers reported holding AVROBIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10 | +66.7% | 6,388 | 0.0% | 0.00% | – |
| Q2 2023 | $6 | +200.0% | 6,388 | +219.4% | 0.00% | – |
| Q1 2023 | $2 | +100.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 2,000 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 2,000 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -62.5% | 2,000 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | -55.6% | 2,000 | 0.0% | 0.00% | – |
| Q2 2021 | $18,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2021 | $18,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2020 | $18,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2020 | $18,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2020 | $18,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2020 | $18,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2019 | $18,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2019 | $18,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2019 | $18,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2019 | $18,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 4,001,627 | $6,162,506 | 5.66% |
| Vazirani Asset Management LLC | 468,273 | $721,140 | 1.10% |
| Atlas Venture Life Science Advisors, LLC | 4,541,381 | $6,993,727 | 1.08% |
| Terrapin Asset Management, LLC | 558,787 | $860,532 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 3,512,686 | $5,409,536 | 0.76% |
| Newtyn Management, LLC | 2,000,000 | $3,080,000 | 0.76% |
| Aldebaran Capital, LLC | 470,130 | $724,000 | 0.74% |
| Aisling Capital Management LP | 1,009,779 | $1,555,060 | 0.64% |
| Western Standard LLC | 310,361 | $477,956 | 0.43% |
| Affinity Asset Advisors, LLC | 500,000 | $770,000 | 0.22% |